Harmony Biosciences Holdings, Inc. HRMY
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-08-19
Chart by TradingView
6/9
Piotroski F — financial health
7.17
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $868.5M | $714.7M | $582.0M | $437.9M | $305.4M |
| Gross profit | $670.1M | $557.9M | $460.8M | $354.4M | $249.9M |
| Operating income | $208.5M | $190.8M | $192.0M | $120.2M | $87.5M |
| Net income | $158.7M | $145.5M | $128.9M | $181.5M | $34.6M |
| Operating cash flow | $348.2M | $219.8M | $219.4M | $144.5M | $98.6M |
| Free cash flow | $347.9M | $218.7M | $219.1M | $144.3M | $98.3M |
| Total assets | $1.3B | $999.2M | $811.4M | $673.9M | $433.4M |
| Total liabilities | $401.4M | $340.0M | $344.5M | $271.0M | $246.9M |
| Shareholders' equity | $870.2M | $659.2M | $467.0M | $402.8M | $186.5M |
| Ratios | |||||
| Gross margin | 77.2% | 78.1% | 79.2% | 80.9% | 81.8% |
| Operating margin | 24.0% | 26.7% | 33.0% | 27.4% | 28.7% |
| Net margin | 18.3% | 20.4% | 22.1% | 41.4% | 11.3% |
| FCF margin | 40.1% | 30.6% | 37.6% | 33.0% | 32.2% |
| Return on assets | 12.5% | 14.6% | 15.9% | 26.9% | 8.0% |
| Return on equity | 18.2% | 22.1% | 27.6% | 45.0% | 18.5% |
| Debt / equity | 0.19× | 0.27× | 0.38× | 0.48× | 1.02× |
| Current ratio | 3.60 | 3.31 | 2.75 | 5.07 | 5.29 |
| Revenue growth | 21.5% | 22.8% | 32.9% | 43.4% | 91.2% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 1,077,371 | $30.2M |
| Bridgewater Associates, LP | 251,506 | $7.0M |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 7.17 (safe)
- Working capital / assets 0.515
- Retained earnings / assets 0.127
- EBIT / assets 0.164
- Equity / liabilities 2.168
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001802665 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.